Ballast Point Ventures, a St. Petersburg, Fla., firm affiliated with Raymond James Financial, Inc. closed a $3 million growth equity investment in MolecularMD Corporation, a West Palm Beach, Fla., molecular diagnostic company. BPV was the only investor in the financing.
